A novel, minimally invasive method of determining whether fatty deposits in a coronary artery are restricting blood flow to a patient's heart performed similarly to the standard, more-invasive ...
A novel, minimally invasive computer software-based method that uses artificial intelligence to determine whether plaques in a coronary artery are restricting blood flow to the patient's heart ...
Morning Overview on MSN
Deep brain stimulation is being tested as an option for treatment-resistant depression
A multi-center clinical trial is now enrolling patients to test whether surgically implanted electrodes delivering continuous ...
A novel, minimally invasive computer software-based method that uses artificial intelligence to determine whether plaques in a coronary artery are restricting blood flow to the patient’s heart ...
Results from the Phase 3 VELA clinical trials in adults with moderate-to-severe hidradenitis suppurativa (HS) show that clinical responses ...
UC Berkeley School of Public Health researchers are collaborating with the FDA and industry to make drug clinical trials ...
The FDA's move to incorporate Bayesian statistical methods into clinical trials of drugs and biologics garnered special ...
(Nasdaq: MPLT), a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system disorders, today reported financial results for ...
NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) , a premier artificial intelligence (AI) company transforming clinical trials with AI-powered ...
Abstract: In this paper, we investigate the secret key generation (SKG) for static scenarios utilizing the pilot randomization method. In fact, the majority have studied SKG under dynamic scenarios in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results